Literature DB >> 17089134

Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease.

K A Jellinger1, J Attems.   

Abstract

Neurofibrillary tangle predominant dementia (NFTPD) is a subset of late onset dementia, clinically different from traditional "plaque and tangle" Alzheimer disease (AD): later onset, shorter duration, less severe cognitive impairment, and almost absence of ApoE epsilon4. Neuropathology reveals abundant allocortical neurofibrillary pathology with no or few isocortical tau lesions, absence of neuritic plaques, absence or scarcity of amyloid deposits, but neurofibrillary changes comprising both 3 and 4 repeat (3R and 4R) tau immunohistochemistry are not significantly different from those in classical AD. Comparing 51 autopsy cases of NFTPD with 244 classical AD subjects, the nosology of NFTPD and its differences from AD are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17089134     DOI: 10.1007/s00401-006-0156-7

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  57 in total

1.  Association of APOE with tau-tangle pathology with and without β-amyloid.

Authors:  Jose M Farfel; Lei Yu; Philip L De Jager; Julie A Schneider; David A Bennett
Journal:  Neurobiol Aging       Date:  2015-09-28       Impact factor: 4.673

2.  Modeling regional vulnerability to Alzheimer pathology.

Authors:  Donald R Royall; Raymond F Palmer; Helen Petrovitch; G Webster Ross; Kamal Masaki; Lon R White
Journal:  Neurobiol Aging       Date:  2011-07-30       Impact factor: 4.673

3.  Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.

Authors:  Melissa E Murray; Neill R Graff-Radford; Owen A Ross; Ronald C Petersen; Ranjan Duara; Dennis W Dickson
Journal:  Lancet Neurol       Date:  2011-07-27       Impact factor: 44.182

Review 4.  Primary Age-Related Tauopathy (PART): Addressing the Spectrum of Neuronal Tauopathic Changes in the Aging Brain.

Authors:  Richard A Hickman; Xena E Flowers; Thomas Wisniewski
Journal:  Curr Neurol Neurosci Rep       Date:  2020-07-14       Impact factor: 5.081

5.  Cognitive decline associated with pathological burden in primary age-related tauopathy.

Authors:  Kyra S Jefferson-George; David A Wolk; Edward B Lee; Corey T McMillan
Journal:  Alzheimers Dement       Date:  2017-03-16       Impact factor: 21.566

Review 6.  Challenges of multimorbidity of the aging brain: a critical update.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  J Neural Transm (Vienna)       Date:  2014-08-05       Impact factor: 3.575

Review 7.  Mechanisms of tau-induced neurodegeneration.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong; Alejandra Del C Alonso; Inge Grundke-Iqbal
Journal:  Acta Neuropathol       Date:  2009-01-30       Impact factor: 17.088

Review 8.  Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy.

Authors:  Gabor G Kovacs; Isidro Ferrer; Lea T Grinberg; Irina Alafuzoff; Johannes Attems; Herbert Budka; Nigel J Cairns; John F Crary; Charles Duyckaerts; Bernardino Ghetti; Glenda M Halliday; James W Ironside; Seth Love; Ian R Mackenzie; David G Munoz; Melissa E Murray; Peter T Nelson; Hitoshi Takahashi; John Q Trojanowski; Olaf Ansorge; Thomas Arzberger; Atik Baborie; Thomas G Beach; Kevin F Bieniek; Eileen H Bigio; Istvan Bodi; Brittany N Dugger; Mel Feany; Ellen Gelpi; Stephen M Gentleman; Giorgio Giaccone; Kimmo J Hatanpaa; Richard Heale; Patrick R Hof; Monika Hofer; Tibor Hortobágyi; Kurt Jellinger; Gregory A Jicha; Paul Ince; Julia Kofler; Enikö Kövari; Jillian J Kril; David M Mann; Radoslav Matej; Ann C McKee; Catriona McLean; Ivan Milenkovic; Thomas J Montine; Shigeo Murayama; Edward B Lee; Jasmin Rahimi; Roberta D Rodriguez; Annemieke Rozemüller; Julie A Schneider; Christian Schultz; William Seeley; Danielle Seilhean; Colin Smith; Fabrizio Tagliavini; Masaki Takao; Dietmar Rudolf Thal; Jon B Toledo; Markus Tolnay; Juan C Troncoso; Harry V Vinters; Serge Weis; Stephen B Wharton; Charles L White; Thomas Wisniewski; John M Woulfe; Masahito Yamada; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2015-12-10       Impact factor: 17.088

9.  Con: Can neuropathology really confirm the exact diagnosis?

Authors:  Kurt A Jellinger
Journal:  Alzheimers Res Ther       Date:  2010-05-07       Impact factor: 6.982

Review 10.  Neuropathological assessment of the Alzheimer spectrum.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2020-08-01       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.